Have a personal or library account? Click to login
Novel potential synthetic compounds from thiazolidin-4-one for infectious diseases Cover

Novel potential synthetic compounds from thiazolidin-4-one for infectious diseases

Open Access
|Oct 2018

References

  1. Breidenstein EB, de la Fuente-Núñez C, Hancock RE. Pseudomonas aeruginosa all roads lead to resistance. Trends Microbiol. 2011; 19:419–26.
  2. Abadi ATB. Helicobacter pylori emergence of a superbug. Front Med (Lausanne). 2014; 1:34. fmed.2014.00034
  3. Hawkes M, Barton M, Conly J, Nicolle L, Barry C, Ford-Jones EL. Community-associated MRSA: superbug at our doorstep. CMAJ. 2007; 176:54–6.
  4. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. CDC. 2013; 15–7.
  5. Moellering RC Jr. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus Ann Intern Med. 2006; 144:368–70.
  6. Nazir T, Abraham S, Islam A. Emergence of potential superbug Mycobacterium tuberculosis lessons from New Delhi mutant-1 bacterial strains. Int J Health Sci (Qassim). 2012; 6:87–94.
  7. Pham DT, Vo TMH, Truong P, Ho PT, Nguyen MQ. Antimicrobial activity of some novel 2-(2-iodophenylimino)-5-arylidenethiazolidin-4-one derivatives. Asian Biomed (Res, Rev, News). 2017; 11:405–12.
DOI: https://doi.org/10.1515/abm-2018-0013 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 393 - 393
Published on: Oct 10, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2018 , published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.